Safety and Efficacy of Off-label use of Ivabradine in Patients with Acute Heart Failure
ConclusionThe results of this pilot study demonstrated the safety of the early use of ivabradine alone versus beta-blockers when tolerated, in patients admitted with acute HF (both acutely decompensated as well as de novo). Patients in both groups achieved comparable reduction in heart rate with improvement in functional capacity and exercise tolerance.
Source: Journal of the Saudi Heart Association - Category: Cardiology Source Type: research
More News: Beta-Blockers | Cardiology | Heart | Heart Failure | Middle East Health | Saudi Arabia Health | Sports Medicine | Study